Figure 4. The ART Cohort Collaboration: Risk of Developing New AIDS-Defining Disease or Death After 3 Years Based on CD4 Cell Count and HIV RNA Level at the Time of Initiation of Antiretroviral Therapy
The analysis is based on 12,574 antiretroviral-naïve adult patients who started on antiretroviral therapy that consisted of a combination of at least 3 medications. An AIDS-defining illness was based on the 1993 CDC classification (except those persons who developed a CD4 count less than 200 cells/mm3 were not classified as having a new AIDS-defining illness). Figure based on data from Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-29.
From: HIV Web Study <www.hivwebstudy.org>